Estimated Population-Level Impact of Using a Six-Week Regimen of Daily Rifapentine to Treat Latent Tuberculosis Infection in the United States.
Sourya ShresthaAndrea ParriottNicolas A MenziesPriya B SheteAndrew N HillSuzanne M MarksDavid W DowdyPublished in: Annals of the American Thoracic Society (2021)